Baxter Healthcare Corporation is recalling approximately 5,940 bottles of Sevoflurane, USP Inhalation Anesthetic (250 mL). This prescription medication is being recalled because the product failed stability specifications during testing, which means the drug may not maintain its required quality or potency throughout its shelf life. Consumers should immediately check their supplies for the specific lot number affected by this recall.
The failure to meet stability specifications can lead to the drug losing its effectiveness or developing impurities over time, which may result in unpredictable anesthesia depth or other adverse clinical outcomes during surgery.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.